Cannara Historical Valuation

LOVE Stock  CAD 0.78  0.08  11.43%   
Some fundamental drivers such as market cap or Cannara Biotech enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Cannara Biotech valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Cannara Biotech's future value.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Cannara Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About Cannara Valuation Data Analysis

Valuation is the financial process of determining what Cannara Biotech is worth. Cannara Biotech valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Cannara Biotech valuation ratios help investors to determine whether Cannara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannara with respect to the benefits of owning Cannara Biotech security.

Cannara Biotech Valuation Data Chart

Market Cap is likely to climb to about 128.1 M in 2024. Enterprise Value is likely to climb to about 143.2 M in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as Cannara Biotech theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Cannara Biotech debt, but would also pocket its cash. Enterprise Value is more accurate representation of Cannara Biotech value than its market capitalization because it takes into account all of Cannara Biotech existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cannara Stock Analysis

When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.